MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cummins, T. R.
Right arrow Articles by Dib-Hajj, S. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cummins, T. R.
Right arrow Articles by Dib-Hajj, S. D.

Vol. 61, Issue 5, 1192-1201, May 2002

Critical Molecular Determinants of Voltage-Gated Sodium Channel Sensitivity to µ-Conotoxins GIIIA/B

Theodore R. Cummins, Fabio Aglieco, and Sulayman D. Dib-Hajj

Department of Neurology and PVA/EPVA Neuroscience Research Center, Yale University School of Medicine, New Haven, Connecticut; and Rehabilitation Research Center, Veterans Affairs Medical Center, West Haven, Connecticut

GIIIA/B µ-conotoxins block the rat skeletal muscle sodium channel (rNav1.4) with high affinity by binding to specific residues in the pore. However, human Nav1.4 (hNav1.4) channels, which are resistant to block by GIIIA/B, have these same pore residues. We used chimera constructs, site-directed mutagenesis, and electrophysiological techniques to investigate which residues determine GIIIA/B selectivity. Exchange of serine 729 in the D2/S5-S6 linker of rat Nav1.4 with leucine (S729L), the corresponding residue in hNav1.4, reduces the sensitivity of rNav1.4 by ~20-fold and largely accounts for the differential sensitivity of rNav1.4 and hNav1.4 to both GIIIA and GIIIB. To determine whether D2/S5-S6 linker residues might contribute to the resistance of neuronal channels to GIIIA/B, we exchanged residues in this linker that differed between rNav1.4 and neuronal channels. Substitution of aspargine 732 with lysine (N732K), the corresponding residue in rNav1.1a and rNav1.7, reduced the GIIIB sensitivity of rNav1.4 by ~20-fold. The N732K substitution, however, only reduced GIIIA sensitivity of rNav1.4 by ~4-fold, demonstrating that GIIIA and GIIIB have distinct interactions with the D2/S5-S6 linker. Our data indicate that naturally occurring variants in the extra-pore region of the D2/S5-S6 linker contribute to the isoform-specific sensitivity of sodium channels to GIIIA/B. Because S729 and N732 are not part of the high-affinity binding site for µ-conotoxins, these extra-pore residues probably influence the accessibility of the toxin to the binding site within the pore and/or the stability of the toxin-channel complex. Our results should aid the development of toxins that block specific neuronal sodium channel isoforms.


Copyright © 2002 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Biophys. JHome page
Q. Ma, E. Pavlov, T. Britvina, G. W. Zamponi, and R. J. French
Trans-Channel Interactions in Batrachotoxin-Modified Rat Skeletal Muscle Sodium Channels: Kinetic Analysis of Mutual Inhibition between {micro}-Conotoxin GIIIA Derivatives and Amine Blockers
Biophys. J., November 1, 2008; 95(9): 4266 - 4276.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Xiao, J.-P. Bingham, W. Zhu, E. Moczydlowski, S. Liang, and T. R. Cummins
Tarantula Huwentoxin-IV Inhibits Neuronal Sodium Channels by Binding to Receptor Site 4 and Trapping the Domain II Voltage Sensor in the Closed Configuration
J. Biol. Chem., October 3, 2008; 283(40): 27300 - 27313.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. A. Li, I. L. Ennis, T. Xue, H. M. Nguyen, G. F. Tomaselli, A. L. Goldin, and E. Marban
Molecular Basis of Isoform-specific {micro}-Conotoxin Block of Cardiac, Skeletal Muscle, and Brain Na+ Channels
J. Biol. Chem., February 28, 2003; 278(10): 8717 - 8724.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2002 by the American Society for Pharmacology and Experimental Therapeutics